Similar articles

• A target on the move: innate and adaptive immune escape strategies of hepatitis C virus.

  Thimme R, Lohmann V, Weber F. Thimme R, et al. Antiviral Res. 2006 Mar;69(3):129-41. doi: 10.1016/j.antiviral.2005.12.001. Epub 2006 Jan 4. Antiviral Res. 2006. PMID: 16413618 Review.
• [Hepatitis C immunology].

  Alvarado Esquivel C, Leroux-Roels G. Alvarado Esquivel C, et al. Rev Invest Clin. 1999 Sep-Oct;51(5):315-22. Rev Invest Clin. 1999. PMID: 10614142 Review. Spanish.
• Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?

  Godkin A, Ng WF, Gallagher K, Betts G, Thomas HC, Lechler RI. Godkin A, et al. J Allergy Clin Immunol. 2008 May;121(5):1277-1284.e3. doi: 10.1016/j.jaci.2008.01.070. Epub 2008 Mar 19. J Allergy Clin Immunol. 2008. PMID: 18355912
• Immunology of hepatitis B and hepatitis C virus infections.

  Boonstra A, Woltman AM, Janssen HL. Boonstra A, et al. Best Pract Res Clin Gastroenterol. 2008;22(6):1049-61. doi: 10.1016/j.bpg.2008.11.015. Best Pract Res Clin Gastroenterol. 2008. PMID: 19187866 Review.
• Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.

  Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, Bakke A, Bouwer HG, Hinrichs DJ. Rosen HR, et al. Hepatology. 2002 Jan;35(1):190-8. doi: 10.1053/jhep.2002.30293. Hepatology. 2002. PMID: 11786976